Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Aude Charbonnier, MD PhD, Michel Raba, MD, Patrick Ladaique, Laurence Augey, MD, Lilian Laborde, Jeremy Monfray, CRA, Carine Champigneulle, CRA, Mohamad Sobh, Pharm.M., Helene Labussiere-Wallet, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Xavier Thomas, MD PhD, Anne Etienne, MD, Thomas Prebet, MD PhD, Evelyne D'Incan, MD, Jerome Rey, MD, Franck E. Nicolini, MD PhD, Norbert Vey, MD, Mauricette Michallet, MD PhD

Blood (2014) 124 (21): 4288.

https://doi.org/10.1182/blood.V124.21.4288.4288

Published: 2014

Journal Articles

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Jean El-Cheikh, MD PhD, Raynier Devillier, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Boris Calmels, Catherine Faucher, Anne Marie Stoppa, MD, Angela Granata, Claire Oudin, Patrick Ladaique, Claude Lemarie, Geoffroy Venton, Reda Bouabdallah, MD, Christine Zandotti, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4496.

https://doi.org/10.1182/blood.V120.21.4496.4496

Published: 2012

Journal Articles

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Geoffroy Venton, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Sabine Furst, MD, Angela Granata, Claire Oudin, Catherine Faucher, Diane Coso, MD, Reda Bouabdallah, MD, Pierre Berger, Norbert Vey, Patrick Ladaique, Christian Chabannon, MD, PhD, Michele Merlin, Didier Blaise, MD

Blood (2012) 120 (21): 4186.

https://doi.org/10.1182/blood.V120.21.4186.4186

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma: Comparative Analysis of Outcomes Between Unrelated and Related Donor

Jean El-Cheikh, MD PhD, Sabine Furst, MD, Anne Marie Stoppa, Roberto Crocchiolo, MD, Catherine Faucher, MD, Luca Castagna, MD, Angela Granata, Claire Oudin, Patrick Ladaique, Boris Calmels, Claude Lemarie, jean Marc schiano De Colella, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2011) 118 (21): 4513.

https://doi.org/10.1182/blood.V118.21.4513.4513

Published: 2011

Journal Articles

Lenalidomide Followed with Donor Lymphocytes Infusion (DLI) After Allogeneic Stem-Cell Transplantation (Allo-SCT) with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma

Jean El-Cheikh, MD PhD, Roberto Crocchiolo, MD, Patrick Ladaique, Sabine Furst, MD, Luca Castagna, MD, Catherine Faucher, MD, Angela Granata, Claire Oudin, Claude Lemarie, Boris Calmels, Anne Marie Stoppa, jean Marc schiano De Colella, Segolene Duran, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2011) 118 (21): 4310.

https://doi.org/10.1182/blood.V118.21.4310.4310

Published: 2011

Journal Articles

The Association of Fludarabin, Oral Busulfan and Thymoglobulin Prior to Matched-Related Allo-SCT Allows for High Long Term Outcome for Both Patients with Myeloid or Lymphoid Malignancies and Reveals the Impact of CD34+ Graft Cell Dose On Cgvhd and Outcome: Long Term Analysis of a Homogenous Cohort of 100 Consecutive Patients.

Didier Blaise, MD, Laure Farnaut, Benjamin Esterni, MSc, Catherine Faucher, MD, Sabine Furst, MD, Jean El Cheikh, MD, Patrick Ladaique, MD, Norbert Vey, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, MD, Claude Lemarie, Boris Calmels, Luca Castagna, MD, Mohamad Mohty, MD, PhD, Christian Chabannon, MD, PhD

Blood (2009) 114 (22): 3374.

https://doi.org/10.1182/blood.V114.22.3374.3374

Published: 2009

Journal Articles

Donor Stem Cell Source Does Not Impact Outcome of High Risk (HR) Acute Myeloblastic Leukaemia (AML) Patients After Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC-ALLO).

Sabine Furst, MD, Luca Castagna, MD, Thomas Prébet, MD, Claude Lemarie, Jean El Cheikh, MD, Catherine Faucher, MD, Norbert Vey, MD, Aude Charbonnier, MD, PhD, Patrick Ladaique, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2009) 114 (22): 4339.

https://doi.org/10.1182/blood.V114.22.4339.4339

Published: 2009

Journal Articles

Low Relapse without Excessive Transplant-Related Mortality Following Allogeneic Stem Cell Transplantation in Patients with High Risk Secondary Acute Myeloblastic Leukaemia and Myelodysplastic Syndromes, Long-Term Outcomes in a Single Centre Experience.

Jean El-cheikh, MD, Luca Castagna, MD, Sabine Furst, MD, Catherine Faucher, MD, Benjamin Esterni, Patrick Ladaique, Aude Charbonier, Christian Chabannon, MD, PhD, Norbert Vey, Didier Blaise, MD

Blood (2009) 114 (22): 4308.

https://doi.org/10.1182/blood.V114.22.4308.4308

Published: 2009

Journal Articles

Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin

Hugues de Lavallade, Patrick Ladaique, Claude Lemarié, Sabine Fürst, Catherine Faucher, Didier Blaise, Christian Chabannon, Boris Calmels

Blood (2009) 113 (8): 1868–1869.

https://doi.org/10.1182/blood-2008-11-187773

Published: 2009

Journal Articles

Age and Disease Status Are Important Risk Factors for Outcome after Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults

Sabine Fürst, Catherine Faucher, Jean El Cheikh, Jean Marie Boher, Patrick Ladaique, Claude Lemarie, Norbert Vey, Reda Bouabdallah, Anne Marie Stoppa, Hugues de Lavallade, Mohamad Mohty, Christian Chabannon, Didier Blaise

Blood (2008) 112 (11): 4412.

https://doi.org/10.1182/blood.V112.11.4412.4412

Published: 2008

Journal Articles

Graft-Versus Host Disease (GVHD) and Infectious Complications Following Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults.

Sabine Furst, MD, Mohamad Mohty, MD, PhD, Catherine Faucher, MD, Jean El-Cheikh, MD, Patrick Ladaique, MD, Claude Lemarie, Norbert Vey, MD, Reda Bouabdallah, MD, Anne-Marie Stoppa, MD, Nicolas Marchetti, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2007) 110 (11): 4985.

https://doi.org/10.1182/blood.V110.11.4985.4985

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Mohamad Mohty, MD, PhD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Norbert Vey, MD, Diane Coso, MD, Anne-Marie Stoppa, MD, Jean-Albert Gastaut, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2007) 110 (11): 1090.

https://doi.org/10.1182/blood.V110.11.1090.1090

Published: 2007

Journal Articles

Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.

Vadim Ivanov, MD, Catherine Faucher, MD, Patrick Ladaique, MD, Sabine Furst, MD, Mohamad Mothy, MD, Jean El Cheikh, MD, Thomas Prebet, MD, Diane Coso, MD, Jean-Marc Schiano, MD, Frederic Viret, MD, Christian Chabannon, MD, Didier Blaise, MD

Blood (2007) 110 (11): 2997.

https://doi.org/10.1182/blood.V110.11.2997.2997

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Hugues de Lavallade, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Diane Coso, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Danielle Sainty, MD, Christian Chabannon, MD, PhD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 3003.

https://doi.org/10.1182/blood.V108.11.3003.3003

Published: 2006

Journal Articles

The Use of Recombinant Human Erythropoietin (rHuEpo) after Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation (ASCT) Reduce Red Blood Cell (RBC) Transfusion Requirements.

Vadim Ivanov, Jean El Cheikh, Catherine Faucher, Sabine Furst, Mohamad Mohty, Patrick Ladaique, Claude Lemarie, Aude Charbonnier, Diane Coso, Jean Marc Schiano, Frederic Viret, Didier Blaise

Blood (2006) 108 (11): 2988.

https://doi.org/10.1182/blood.V108.11.2988.2988

Published: 2006

Journal Articles

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Patrick Ladaique, MD, Christian Chabannon, MD,PhD, Catherine Faucher, MD, Sabine Furst, MD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrice Viens, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD

Blood (2006) 108 (11): 2989.

https://doi.org/10.1182/blood.V108.11.2989.2989

Published: 2006

Journal Articles

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

Mohamad Mohty, Martin Ferrando, Patrick Ladaique, Catherine Faucher, Sabine Furst, Norbert Vey, Anne-Marie Stoppa, Diane Coso, Frederic Viret, Gwenaelle Gravis, Jean-Albert Gastaut, Didier Blaise

Blood (2005) 106 (11): 961.

https://doi.org/10.1182/blood.V106.11.961.961

Published: 2005

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): A Donor Versus No Donor Comparison.

Mohamad Mohty, Hugues de Lavallade, Patrick Ladaique, Catherine Faucher, Norbert Vey, Diane Coso, Anne-Marie Stoppa, Jean-Albert Gastaut, Didier Blaise

Blood (2005) 106 (11): 5413.

https://doi.org/10.1182/blood.V106.11.5413.5413

Published: 2005

Journal Articles

The Role of Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML): A Donor vs. No Donor Comparison.

Hugue de la Vallade, Mohamad Mohty, Catherine Faucher, Norbert Vey, Diane Coso, Anne-Marie Stoppa, Jean-Albert Gastaut, Patrick Ladaique, Christian Chabannon, Didier Blaise

Blood (2004) 104 (11): 2325.

https://doi.org/10.1182/blood.V104.11.2325.2325

Published: 2004

NARROW

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Risk Factors of GANCICLOVIR–RELATED Neutropenia After Allogeneic STEM CELL Transplantation: A Retrospective Monocenter Study On 547 Patients

Allogeneic Hematopoietic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma: Comparative Analysis of Outcomes Between Unrelated and Related Donor

Lenalidomide Followed with Donor Lymphocytes Infusion (DLI) After Allogeneic Stem-Cell Transplantation (Allo-SCT) with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma

Donor Stem Cell Source Does Not Impact Outcome of High Risk (HR) Acute Myeloblastic Leukaemia (AML) Patients After Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC-ALLO).

Low Relapse without Excessive Transplant-Related Mortality Following Allogeneic Stem Cell Transplantation in Patients with High Risk Secondary Acute Myeloblastic Leukaemia and Myelodysplastic Syndromes, Long-Term Outcomes in a Single Centre Experience.

Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin

Age and Disease Status Are Important Risk Factors for Outcome after Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults

Graft-Versus Host Disease (GVHD) and Infectious Complications Following Reduced Intensity Conditioning (RIC) Umbilical Cord Blood Transplantation (UCBT) in Adults.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

The Use of Recombinant Human Erythropoietin (rHuEpo) after Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation (ASCT) Reduce Red Blood Cell (RBC) Transfusion Requirements.

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): A Donor Versus No Donor Comparison.

The Role of Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML): A Donor vs. No Donor Comparison.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only